Jasper Therapeutics (JSPR) Tax Rate (2020)
Jasper Therapeutics (JSPR) posted Tax Rate of 0.16% for Q4 2020, down 95.82% on a QoQ basis from 3.92% in Q3 2020.
Powered by 
Analysis
Jasper Therapeutics (JSPR) Tax Rate (2020) Analysis & Trends
Jasper Therapeutics has reported Tax Rate for 1 years, with the latest figure at 0.16% in Q4 2020.
- On a quarterly basis, Tax Rate changed N/A year-over-year to 0.16% in Q4 2020; TTM through Dec 2020 was 0.47%, a N/A change from a year earlier, with the FY2020 full-year figure at 0.6%, up 220.0% from the prior year.
- Tax Rate was 0.16% for Q4 2020 at Jasper Therapeutics, down from 3.92% in the prior quarter.
- The five-year high for Tax Rate was 3.92% in Q3 2020, with the low at 0.03% in Q2 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.69 Bn | 192.70 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 179.87 Bn | 176.70 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 81.70 Bn | 73.71 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 54.28 Bn | 49.14 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 33.02 Bn | 29.71 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.93 Bn | 30.64 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 29.27 Bn | 29.27 Bn | 1.16 Mn | 1.34% |
| 10 | Jasper Therapeutics | 20.08 Mn | 20.08 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 0.16% |
| Sep 30, 2020 | 3.92% |
| Jun 30, 2020 | 0.03% |
| Mar 31, 2020 | 3.89% |